The biochemical pathways to cell death in chronic and acute forms of neurodegeneration are poorly understood, limiting the ability to develop effective therapeutic approaches.
other pathologic conditions in which mitochondrial func tion is altered.
This review addresses current concepts of mitochon drial function relevant to normal bioenergetic function, Ca 2 + sequestration, free radical production, and regula tion of the apoptotic pathway to provide a mitochondrial primer relevant to those interested in neurodegeneration. In the April 1999 issue of the Journal of Cerebral Blood Flow and Metabolism, a second review summarizes the current understanding of mitochondrial function during ischemic/reperfusion-induced neuronal death that ac companies stroke, cardiac arrest, and traumatic injury to the brain (Fiskum et aI., 1999) . This second review also addresses recent advances in understanding the role that mitochondrial dysfunction plays in chronic forms of neu rodegeneration, including Alzheimer's disease, Parkin son's disease, amyotrophic lateral sclerosis, and Hun tington's Disease. Our need to understand the underlying mechanisms of aging, including mitochondrial dysfunc tion and free radical-induced oxidative damage (Beal, 1995) is intensifying as the population is becoming more elderly. Experimental support continues to accumulate for a central role of defective energy metabolism, alter ation in mitochondrial function leading to increased free radical production, and active mitochondrial participa tion in the apoptosis cascade in the pathogenesis of acute and chronic neurodegeneration.
NECROTIC VERSUS APOPTOTIC DEATH IN NEURODEGENERA TION
It is reasonable that ischemic necrotic death, such as the necrosis that occurs at the core of an infarct, results from either acute or delayed loss of ionic homeostasis and osmotic cell lysis resulting from a lack of mitochon drial and glycolytic ATP production. Whether mitochon drial dysfunction contributes to necrotic neuronal death in chronic forms of degeneration is less clear. However, it is at least theoretically possible that defects in mito chondrial electron transport (Fiskum et aI., 1999) could be severe enough to compromise total cellular A TP pro duction and thereby result in necrosis. Such a proposal will remain primarily theoretical until we gain a better understanding of the mechanisms by which neurons are dying in chronic forms of degeneration.
For mitochondrial participation in apoptotic triggering (see Mitochondria as the Apoptotic Trigger) to be rel evant to neurodegeneration, it must first be convincing that apoptosis is contributing to neuronal loss. Because of the current inability to easily discriminate between apoptotic and necrotic cells in tissue preparations, this topic is controversial but has been dealt with in a review by MacManus and Linnik (1997) , which addresses the role that apoptotic death plays after cerebral ischemia. In addition, Martin et aI. (1998) have proposed that death in neurodegeneration involving excitotoxicity exists along a continuum between apoptosis and necrosis. There also is evidence for apoptosis occurring in traumatic injury to CNS neurons (see Crowe et aI., 1997, and references therein) . Keeping the concerns over methodology in mind (MacManus and Linnik, 1997) , the evidence for apoptotic death in chronic forms of neurodegeneration is accumulating. Apoptotic nuclei are evident in tissue from patients with Parkinson's disease (Mochizuki et aI., 1996) , amyotrophic lateral sclerosis (Yoshiyama et aI. 1994 ), Huntington's disease (Thomas et aI., 1995) , and Alzheimer's disease (Smale et aI., 1995; Anderson et aI., 1996; Su et aI., 1996; Su et aI., 1997; Troncoso et aI., 1996) . It is possible that mitochondrial involvement in some forms of neurodegeneration, including Alzheimer's disease, arises primarily from chronic neuronal dysfunc tion associated with a state of near but not complete cell death, which induces functional impairment of the tissue.
The endogenous protein regulators of apoptosis are relevant to the current discussion. Providing a historical review of the Bcl-2 family of proteins and the caspase family of cysteine proteases, however, is beyond the scope of this work. The reader is urged to refer to several recent reviews on these subjects (Reed, 1997; Bredesen, 1996; Nicholson and Thornberry, 1997) . The Bcl-2 fam ily, which includes both inhibitors (such as Bcl-2 and Bcl-xL) and activators (such as Bax and Bad) are key regulatory molecules at the point in apoptosis where di-J Cereb Blood Flow Metab, Vol. 19, No. 3, 1999 verse pathways converge, potentially on the release of mitochondrial apoptogenic factors. Certain members of the caspase family of cysteine proteases (especially caspase-3 and caspase-9) lie downstream in the bio chemical pathway from mitochondria and Bcl-2 family regulators (Chinnaiyan et aI., 1996; Liu et aI., 1996; Susin et aI., 1996; Xiang et aI., 1996; Kluck et aI., 1997; Yang et aI., 1997; Ellerby et aI., 1997) . Other caspases (especially caspase-8) lie upstream from mitochondrial events, as in the apoptotic pathway induced by tumor necrosis factor receptor family members (Boise and Thompson, 1997; Susin et aI., 1997; Adachi et aI., 1997) .
MITOCHONDRIAL ELECTRON TRANSPORT

AND THE PROTONMOTIVE FORCE
Critical to a discussion of mitochondria in cellular degeneration is an understanding of mitochondrial elec tron transport, and the resulting ability of mitochondria to sequester Ca 2 + and to generate superoxide radical. Mitochondrial electron transport ( Fig. 1 ) involves provi sion of reducing equivalents in the form of NADH or FADH 2 to components of the chain as the result of the enzyme-catalyzed oxidation of fuel molecules. The re sulting oxidation/reduction reactions successively shuttle these electrons from the component of more negative redox potential ultimately to O 2 , As a function of these redox reactions, protons are pumped by complex I, ubi quinone/complex III, and complex IV from the matrix to the cytosolic side of the inner mitochondrial membrane. As a result, the energy of fuel molecules is converted into a form of potential energy called the electrochemical gradient of protons (Llf..l H +' expressed in kJ mol-I) or the protonmotive force (Llp, expressed in millivolts). Ulti mately, the protonmotive force is used to perform work in the form of ATP synthesis by the A TP synthetase (termed oxidative phosphorylation), or ion, metabolite, and protein transport.
The gradient generated by mitochondrial electron transport has both an electrical (Lllji) and a chemical com ponent (LlpH). Under normal conditions, the contribution of the pH gradient to the total protonmotive force is relatively small. For instance, it has been estimated that when the total protonmotive force under state 4 (resting) conditions is 200 mY, Lllji is approximately 170 mV and the pH gradient is approximately 0.5 pH units (alkaline inside) or equivalent to 30 m V (Nicholls and Ferguson, 1992) . This issue is relevant because certain transport processes are driven primarily by Lllji (for instance, Ca 2 + uptake), and some are driven primarily by LlpH. For instance, LlpH drives phosphate transport, which func tions in isolated mitochondria to maintain LlpH at a rela tively constant value during changes in respiration induced proton pumping), and drives K+/H+ antiport, which is involved in mitochondrial volume regulation (Brierley et aI., 1994) .
FIG. 1. Mitochondrial electron transport, the electrochemical gradient of protons, and oxida tive phosphorylation (see Ni cholls and Ferguson [1992] for details). The flavin moiety of succinate dehydrogenase is a covalently bound cofactor of the enzyme, which is embed ded in the inner membrane. Depending on the tissue type, additional complexes exist (not shown) , which can donate electrons to ubiquinone. DH, dehydrogenase (oxidoreduc tase); UQ, ubiquinone; �p, proton motive force; �I\J, mem brane potential; MPP+, 1-methyl-4-phenylpyridinium; 3-NP, 3-nitropropionic acid; anti A, antimycin A; eN, cya nide.
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The activity of the electron transport chain can be measured using an O 2 electrode with isolated mitochon dria or cells in which the plasma membrane has selec tively been made permeable with digitonin, a technique most amenable to suspensions of cells. Such assays yield information about the maximal rates of electron transfer, as well as the degree of coupling of electron transport to ATP production. Rates of state 3 (phosphorylating) res piration are measured in the presence of oxidizable sub strates and ADP and reflect the maximal rate of coupled respiration, that is, when electron transport is coupled to ATP synthesis. This rate typically is limited in healthy mitochondria by the kinetics of either the ATP synthe tase or the rate of adenine nucleotide translocase (ANT) mediated provision of ADP for synthetase activity through antiport of extramitochondrial ADP and intra mitochondrial ATP. However, under pathologic condi tions (including Ca 2 + or free radical-mediated injury), the activity of certain components of the electron trans port chain may become rate limiting, placing a restriction on the protonmotive force that can be generated or po tentiating mitochondrial free radical production (see later). State 4, or "resting" respiration, can be measured in the absence of ADP or the presence of the A TP syn thetase inhibitor oligomycin, and reflects the rate of leak age of protons back across the inner mitochondrial mem brane into the matrix. State 4 rates increase when the integrity of the inner mitochondrial membrane has been compromised, such as during opening of the mitochon drial permeability transition pore (see later) or as a result of Ca 2 + or free radical-induced damage. The maximal rate at which substrate oxidation and electron flow ATP + through the chain to O 2 can take place in the absence of the rate restrictions imposed by the synthetase, or the ANT can be measured by the addition of an uncoupler such as carbonyl cyanide p-trifluoromethoxyphenyl hy drazone (FCCP). Such agents act as ionophores to allow H+ to move down their concentration gradient into the matrix, thus dissipating i.lp and removing the driving force for mitochondrial work. Such measurements iden tify specific sites of alterations in mitochondrial function (Adachi et aI., 1997; Murphy et aI., 1990) and greatly enhance understanding of measurements of i.lljJ. Fluoro metric measurements of i.lljJ can be ambiguous under certain circumstances, because a drop in membrane po tential can arise for numerous reasons, including Ca 2 + transport, respiratory uncoupling, or respiratory inhibi tion.
What is the consequence of altered electron transport to neuronal viability? If severe enough, electron transport inhibition compromises the ability to generate an elec trochemical gradient and, therefore, decreases the rate of ATP synthesis (Davey and Clark, 1996) . This, in turn, may establish conditions for secondary excitoxicity (Henneberry, 1997) . In addition, mitochondrial free radi cal generation may be enhanced (see Mitochondrial Re active Oxygen Species Generation). Ultimately, either apoptotic or necrotic death, or chronic cellular dysfunc tion may result. The pathway taken by the cell may be partly dependent on the cellular ATP level, a function of the rates of mitochondrial and glycolytic A TP production and the rate of energy utilization. Studies support that apoptosis occurs only if there is sufficient ATP to ex ecute the process (Eguchi et aI., 1997; Leist et aI., 1997) .
Electron transport inhibition with cyanide when com bined with glucose deprivation can result in either acute cell death (within 1 hour) if ATP levels are depleted for a sufficient amount of time, or delayed cell death (within 24 hours) if electron transport inhibition and ATP deple tion is brief (Myers et aI., 1995) . When electron transport is inhibited and glycolytic ATP production continues by provision of glucose, the outcome also can be either ne crotic or apoptotic death, presumably dependent on the ability of glycolysis to meet cellular energy demands. Chronic inhibition of succinate dehydrogenase with 3-ni tropropionic acid (a model of Huntington's disease) can induce apoptotic (Behrens et aI., 1995; Pang and Geddes, 1997) and necrotic (Pang and Geddes, 1997) death in primary cultures of neurons. Apoptosis may be induced in vitro or in vivo by administration of the complex I inhibitor l-methyl-4-phenylpyridinium (a model of Par kinson's disease) or the complex II inhibitor 3-nitropro pionic acid (Dipasquale et aI., 1991; Hartley et al. 1994; Sheehan et aI., 1997; Sato et aI., 1997; Tatton and Kish, 1997) . In addition, chronic hypoxic treatment of several cell types induces delayed cell death (Jacobson and Raff, 1995; Shimizu et aI., 1995) . Relevant to later discussion, in many of these studies, substrates for cytoplasmic A TP production were provided. Therefore, a mitochondrial membrane potential can be maintained as a result of reversal of the proton-pumping activity of the ATP syn thetase. The inclusion of oligomycin, an inhibitor of the synthetase, blocks this process (Budd and Nicholls, 1996a) . The electrical component of the proton gradient, LltjJ, can be used to drive the uptake of Ca 2 + into the matrix (see Gunter et aI., 1994; and Gunter and Pfeiffer, 1990, for review) . Figure 2 depicts the transport processes in volved in mitochondrial Ca 2 + homeostasis in electrically excitable cells. Mitochondrial Ca 2 + transport is relevant because of the role of excitotoxic and ischemic events in acute forms of neurodegeneration. It also is potentially applicable if mitochondrial defects in chronic forms of degeneration are severe enough to compromise normal fluctuations in ion gradients in response to neurotrans mitter stimulation. Mitochondrial Ca 2 + uptake occurs when the extramitochondrial concentration rises above what is termed the mitochondrial "buffer" or "set point," the concentration at which the Ca 2 + uniporter becomes more active than the Ca 2 + efflux mechanism. Nicholls and Scott (1980) estimate the set point of brain mitochondria to be approximately 0.5 f,LmollL. However, enhanced sensitivity to the concentration of adenine nucleotides (Rottenberg and Marbach, I 990a,b) and spa tiotemporal variables imply that mitochondrial Ca 2 + se questration may occur in subpopulations of mitochondria in a manner that is not predicted by the overall cytoplas mic Ca 2 + value (Rizzuto et aI., 1998) . Although Na+, polyanions such as spermine, and adenine nucleotides can alter the buffer point in vitro (Gunter and Pfeiffer, 1990; Rottenberg and Marbach, 1990a, b; Murphy and Fiskum, 1988) , it is not known to what degree this value Mitochondrial Ca2+ transport mechanisms. The Ca2+ efflux mechanism de picted is believed to be that which operates in the mito chondria of electrically excit able tissues. Alternatively, for instance, in liver mitochondria, efflux may be mediated by Ca2+/2H+ anti port. Efflux through the Na+/Ca 2 + ex changer is influenced by the Na+/W antiporter that is driven by �pH. See Gunter and Pfeiffer (1990) and Gunter et al. (1994) for further discus sion.
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Matrix varies physiologically, nor is it known how it varies from one neural cell type to another. Because of the rapid kinetic capability of the uniporter (which may have two kinetic modes of operation [Sparagna et aI., 1995] ) and the slow V max of the Ca 2 + efflux mechanism (a Na+/Ca 2 + antiporter in mitochondria of electrically excitable cells), net Ca 2 + sequestration can occur. Also, because of the velocity of the uniporter, Ca 2 + uptake will deplete �t\J and stimulate electron transport until extramitochondrial Ca 2 + is lowered below the set point. Sequestered Ca 2 + will then exist in equilibrium with protein and lipid Ca 2 + binding sites and osmotically inactive Ca 2 + (the latter of which represents most of matrix calcium). Provided that extramitochondrial Ca 2 + remains below the set point and the load of mitochondria Ca 2 + is physiologic, matrix free [Ca 2 +] then will slowly decrease, the rate of which is dependent on extramitochondrial [Na+], �pH, and, pos sibly, other physiologic effectors that await characteriza tion.
Relatively low levels of mitochondrial Ca 2 + seques tration, such as that which follows normal depolariza tion, acts in a bioenergetic signaling capacity by stimu lating matrix Ca 2 + -sensitive dehydrogenase activity. This increases provision of reducing equivalents to the elec tron transport chain, enhancing ATP synthesis to meet the increased cellular energy demand (Gunter and Pfeiffer, 1990) . Higher levels of sequestration have been reported to induce Ca 2 +-induced Ca 2 + release, which may play an important role in the propagation of Ca2+ signals (Ichas and Mazat, 1998) . Above a certain level, however, Ca 2 + sequestration can begin to compromise mitochondrial function, resulting in respiratory inhibition or uncoupling of oxidative phosphorylation, formation of nonspecific pores (see later), or osmotic lysis. Respira tory inhibition (if severe enough) and uncoupling lower the measured mitochondrial membrane potential. There fore, a Ca 2 +-induced drop in �t\J may be followed by Ca 2 +-induced injury to electron transport and the inner mitochondrial membrane, or Ca 2 +-induced cytochrome c release, which could sustain the loss of membrane po tential.
On the cellular level, the consequences of extensive mitochondrial Ca 2 + sequestration (which has a signifi cantly greater capacity than accumulation by the endo plasmic reticulum) to neuronal cytosolic Ca 2 + levels, mi tochondrial membrane potential, and mitochondrial free radical production indicate that mitochondrial Ca 2 + load ing likely is a critical event in the determination of neu ronal viability after excitotoxic stress (Stout et aI., 1998; Budd and Nicholls, 1996b; Harrington et aI., 1996; Schinder et aI., 1996; White and Reynolds, 1996; Wang and Thayer, 1996; Ankarcrona et aI., 1995; Reynolds and Hastings, 1995; Dugan et aI., 1995 , Bindokas et aI., 1995 . Hartley and coworkers (1993) suggest that the total amount of Ca 2 + that enters the cell correlates better with toxicity than the cytosolic Ca 2 + load, as though an unidentified noncytosolic pool was responsible for tox icity. Although conventional dyes such as fura-2 may have underestimated the level of Ca 2 + reached in the cytoplasm after NMDA exposure (Hyrc et aI., 1997) , it is tempting to modify the excitotoxic theory of neuronal death to more specifically state that the degree of mito chondrial Ca 2 + loading after a stimulus may be the de termining factor in cell death. White and Reynolds (1996) indicate that in forebrain neurons responding to excitotoxic concentrations of glutamate, inhibition of the mitochondrial Na+/Ca 2 + exchanger (the Ca 2 + efflux mechanism) with CGP-37157 enhances the rate and pro portion of mitochondria that lose membrane potential. Ankarcrona et al. (1995) suggest that those cerebellar granule cells treated with a high concentration of gluta mate in which mitochondria depolarize and never re cover membrane potential go on to die by necrosis. In contrast, those neurons that lose mitochondrial mem brane potential during glutamate exposure, but recover �t\J within 30 minutes after removal of excitotoxin, die by apoptosis. Stout et al. (1998) and Budd and Nicholls (l996b) have made the significant finding that dissipa tion of �t\J in neurons (which prevents mitochondrial Ca 2 + sequestration) during glutamate exposure prevents cell death. These data argue that glutamate toxicity is relatively unrelated to the peak and plateau values of cytoplasmic Ca 2 + but is directly related to mitochondrial Ca 2 + sequestration.
MITOCHONDRIAL REACTIVE OXYGEN
SPECIES GENERATION
Excessive Ca 2 + accumulation can potentiate neuronal mitochondrial superoxide production (Dykens, 1994; Reynolds and Hastings, 1995; Dugan et aI., 1995 , Bin dokas et aI., 1996 . Studies initiated approximately 25 years ago (Boveris and Chance, 1973; Cadenas and Boveris, 1980) characterized the ability of isolated mi tochondria to generate superoxide, typically measured as H 2 0 2 (because of spontaneous dismutation of superoxide and endogenous activity of Mn-superoxide dismutase). Experiments with isolated heart and liver mitochondrial suggest that these organelles produce superoxide radical through either autooxidation of the flavin component of complex I of the electron transport chain (NADH dehy drogenase) or through autooxidation of ubi semiquinone at complex III ( Fig. 3 ; Boveris and Chance, 1973; Boveris et aI., 1976; Turrens and Boveris, 1980) . In gen eral, early studies suggest that H 2 0 2 production is maxi mal under conditions of severe mitochondrial respiratory inhibition when the electron carriers responsible for free radical production are maximally reduced (such as in the presence of the complex III inhibitor antimycin A). Such data predict that if damage or mutation occurs to an Mitochondrial Superoxide Production
Intennembrane Space electron transport chain component (or if a component such as cytochrome c is lost from the intermembrane space) that forces a proximal free radical producing site to shift to a more reduced state, then mitochondrial re active oxygen species (ROS) generation will be en hanced. For instance, if electron transport by complex III or IV or cytochrome c becomes severely rate limiting, then free radical production at ubiquinone (and possibly complex I) may be enhanced (see Cai and Jones, 1998) . Therefore, since the redox status of electron transport chain components when mitochondria are in state 3 or are uncoupled is relatively oxidized, then free radical production under these conditions is minimal (Boveris and Chance, 1973) . Somewhat counterintuitively, these early studies indicate that the rate of H 2 0 2 production could be enhanced when antimycin A was combined with an uncoupling agent (a protonophore) (Boveris and Chance, 1973) . Consistent with the conclusions of the early work, recent studies by others (1995, 1996a,b) describe that Ca 2 + stimulation of H 2 0 2 production by uncoupled liver mitochondria is associated with a shift in the redox state of ubiquinone to a more reduced level. Studying conditions relevant to ischemia! reperfusion injury and excitotoxicity, Dykens (1994) has demonstrated that isolated brain mitochondria increase ROS generation when exposed to high extramitochon drial Ca 2 +, Na+, and ADP. Furthermore, evidence was provided that mitochondrial free radical production is likely self-amplifying because of the susceptibility of electron transport to free radical-induced inhibition (Dykens, 1994) . Cai and Jones (1998) chondrial superoxide generation is stimulated by the loss of cytochrome c from the intermembrane space. Whether cytochrome c release is involved in the enhanced ROS production described in some of the aforementioned studies requires further investigation.
On the intact cell level, fluorescence imaging studies document Ca 2 + sequestration-induced stimulation of mi tochondrial ROS generation relevant to neurodegenera tion. Using primary cultures of neurons, Reynolds and Hastings (1995) , Dugan et al. (1995) , and Bindokas et al. (1996) have provided evidence for NMDA receptor ac tivation-induced increases in ROS generation by a source that appears to be mitochondrial. This response was de pendent on extracellular Ca 2 + and was insensitive to in hibitors of nitric oxide synthase or arachidonate metabo lism (Reynolds and Hastings, 1995; Dugan et aI., 1995) . In contrast, K+ depolarization did not induce mitochon drial ROS generation (Dugan et al. 1995; Bindokas et aI., 1996) . As a cautionary note, work by Budd et al. (1997) indicates that certain ROS-sensitive fluorescent dyes can yield misleading data under conditions in which mito chondria may depolarize. In vivo data supporting the premise that mitochondria are a primary source of ROS in ischemia!reperfusion injury has been provided only recently and is reviewed in Fiskum et al. (1999) .
MITOCHONDRIAL MEMBRANE
PERMEABILITY TRANSITION
If the degree of mitochondrial Ca 2 + loading during excitoxic events is critical to determining whether a neu ron will remain viable or will undergo either necrosis or apoptosis, then what is the critical Ca 2 +-stimulated mi tochondrial event? The answer to this question is cur rently unresolved; however, it is known that excessive Ca 2 + sequestration, as well as other stimuli, can induce the mitochondrial membrane permeability transition in mitochondria of certain tissues. This event represents the opening of a nonspecific, voltage-sensitive proteinacious pore (PTP), which allows solutes of less than 1500 dal tons (d) (including Ca 2 +, glutathione, and pyridine nucleotides) to equilibrate across the membrane. A lower conductance state of the pore may be induced by more physiologic levels of mitochondrial Ca 2 + sequestration, which may operate to release sequestered Ca 2 + (Ichas and Mazat, 1998) . Opening of the high-conductance pore induces a maximal rate of substrate oxidation and O 2 consumption in a futile attempt by the mitochondria to establish an electrochemical gradient. Provided that the transition occurs in a sufficient population of mitochon dria, this event should induce a decrease in the measured �ljJ. Pore formation also sustains a drop in �ljJ induced by Ca 2 + or other stress that compromises membrane poten tial. In other words, a measured drop in �ljJ in response to high extramitochondrial Ca 2 + may have two phases, the first involving a Ca 2 + uniporter-induced drop, fol lowed by a second phase resulting from Ca 2 + stimulation of pore formation. However, a measured drop in mito chondrial membrane potential is not automatically in dicative of pore formation. Based on the behavior of isolated mitochondria suspended in isotonic buffers, sus tained PTP opening or, for that matter, any significant loss in mitochondrial inner membrane integrity in an FIG. 4. The mitochondrial membrane permeability transi tion and apoptogen release. See Zoratti and Szabo (1995) for further discussion. ETC, electron transport chain.
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Stimulation of the Late Steps:��""'" of Apoptosis intact cell, may result in mitochondrial swelling (which is the result of a high concentration of relatively fixed charges associated with the proteins and phospholipids within and surrounding the matrix). Whether swelling results from pore formation in an intact cell is still de bated. �ljJ can be recovered after pore closure, provided that pore opening does not persist to a point at which swelling induces irreparable damage to membranes or the pyridine content is insufficient.
Comprehensive reviews of PTP regulation have been provided (Bernardi et aI., 1994; Zoratti and Szabo, 1995) . Pore formation has been studied primarily by measuring large-amplitude swelling of isolated mito chondria in sucrose-containing buffers. The pore can be induced by a significant increase in matrix Ca 2 + (espe cially in the presence of inorganic phosphate) and is potentiated by a decrease in �ljJ or by treatment with prooxidants. Characterized pro oxidants include tert butylhydroperoxide (which results in glutathione or pyr idine nucleotide oxidation), metabolic oxidants (such as acetoacetate or oxaloacetate), quinone cycling com pounds, and sulfhydryl derivatizing or oxidizing agents such as phenylarsine oxide or diamide (Fig. 4) . Evidence also suggests that a step in the process of pore formation involves mitochondrial free radical production. Kowal towski and others (1996a, b) have found that pore forma tion in isolated Ca 2 + -loaded rat liver mitochondria in response to either inorganic phosphate or a loss in �ljJ induced by uncoupler is dependent on mitochondrial free radical production.
Physiologically, pore formation can be inhibited by high LitiJ, elevated NAD(P)HINAD(Pt, sufficient gluta thione to maintain critical sulfhydryls in a reduced state, extramitochondrial Mg 2 +, and ATP or ADP. In addition, data have been provided that a decrease in matrix pH inhibits pore formation (Bernardi et aI., 1992) . Pharma cologically, the pore typically can be inhibited by the immunosuppressant agent cyclosporin A (CsA), phos pholipase A 2 inhibitors, and sulfhydryl reducing agents (at certain concentrations). CsA has been proposed to inhibit the PTP by binding to cyclophilin D in the mito chondrial matrix (Nicolli et aI., 1996; Connern and Hal estrap, 1996) . Other biological activities of CsA include binding to cytosolic cyclophilins. This CsA-cyclophilin complex can bind and inhibit calcineurin, a cytoplasmic Ca 2 + /calmodulin-dependent serine/threonine phospha tase (type 2B), which is enhanced in concentration in neural tissue (Steiner et aI., 1992) . The inhibition of cal cinerin activity appears to be responsible for the immu nosuppressant properties of CsA (see Kunz and Hall, 1993) . The protein components of the pore are currently un known; however, there is compelling evidence that the ANT is involved in pore formation (Zoratti and Szabo, 1995) , and directly binds cyclophilin-D (Woodfield et aI., 1998) . Bongkrekic acid, which stabilizes the translo cator in the "M" conformation (for matrix-facing), is a good PTP blocker, whereas atractyloside and carboxy atractyloside, which stabilize the ANT in the "C" (cy tosol-facing) conformation, are good pore inducers. An other proposed component is the voltage-dependent an ion channel (see Zoratti and SzabO, 1995) . The complex of the ANT, voltage-dependent anion channel, and an 18-kd protein has been suggested to form the mitochon drial benzodiazepine receptor of rat brain (McEnery et aI., 1993) . Potential regulatory components include mi tochondrially associated hexokinase or creatine kinase. The possibility that other large conductance pores may form in the mitochondrial membrane under certain con ditions also should be considered. Sokolove and Kinally (1996) suggest that amphiphilic peptides, which struc turally mimic the signal sequence for mitochondrial pro tein import, can induce the formation of a pore that ap pears to be distinct from the PTP, most notably in re quirement for rather than inhibition by LitiJ.
Although the characteristics of the PTP have been studied for years, direct evidence that the PTP opens in intact cells has been provided only recently. Researchers have used either a fluorescent dye (Zahrebelski et aI., 1995; Nieminen et aI., 1995; Nieminen et aI., 1997; Bradham et aI., 1998) or a radiolabel (Pastorino et aI., 1994) to detect an increase in matrix-accessible space that was inhibited by agents known to block the pore in isolated mitochondria. These studies provide evidence that the PTP plays a critical role in hepatocyte necrosis (in response to tert-butylhydroperoxide, chemical hyp- Vol. 19, No. 3, 1999 oxia/aglycemia, or rotenone) and apoptosis (in response to tumor necrosis factor). Numerous, less-direct studies document an ability of pore inhibitors, including CsA to, protect cells (especially hepatocytes) or perfused tissues from prooxidants, anoxia, Ca 2 + mobilizing agents, or ischemia/reperfusion.
A definitive role of the PTP in induction of neuronal death is less clear. Studies of a neural version of the PTP using isolated brain mitochondria suggest that physi ologic concentrations of Mg 2 + and adenine nucleotides are potent inhibitors of the transition (Rottenberg and Marbach, 1990b; Kristal and Dubinsky, 1997; Andreyev et aI., 1998) . However, no direct measurements of in creased matrix-accessible space in the neuronal death pathway have been reported. Kristal and Dubinsky (1997) report Ca 2 + -or phosphate-induced changes in morphologic features of mitochondria in cultured astro cytes and isolated brain mitochondria that were sensitive to agents known to block large-amplitude swelling in liver mitochondria. Consistent with pore formation in neurons are observations that CsA or inhibitors of phos pholipase A 2 can attenuate or delay glutamate-induced losses in LitiJ (Hoyt et aI., 1997; White and Reynolds, 1996; Schinder et aI., 1996; Nieminen et aI., 1996) , and can block excitoxic neuronal death (Dawson et ai. 1993; White and Reynolds, 1996; Schinder et a!. 1996; An karcrona et aI., 1996) . CsA also protects against death and seizure activity after transient forebrain ischemia or hypoglycemia (Uchino et aI., 1995; Li et aI., 1997b; Fri berg et aI., 1998) . However, recent evidence for involve ment of CsA-inhibitable calcineurin activity in Ca 2 + mediated cell death (Shibasaki and McKeon, 1995; An karcrona et aI., 1996) suggests that this ability to inhibit excitotoxic neuronal death does not result exclusively from inhibition of the PTP. Such skepticism is supported by evidence that other compounds such as FK506, which also inhibits calcineurin yet has no effect on the PTP (Griffiths and Halestrap, 1991) , can be neuroprotective. Specifically, in cortical neurons exposed to excitotoxic concentrations of NMDA, calcineurin inhibition by ei ther CsA or FK506 is known to inhibit dephosphoryla tion of nitric oxide synthase, thereby inhibiting its enzy matic activity, which can contribute to the free radical component of excitoxic death (Dawson et aI., 1993) . Fur ther complications include reports of cytotoxic effects of CsA on neurons (McDonald et a!., 1996; Mosieniak et aI., 1997) . Therefore, conclusive identification of the pore components and development of pore-specific in hibitors are critical to the ability to clearly define the role of the PTP in all forms of cell death. Although it is not currently clear that the PTP is completely responsible, there is substantial evidence that altered mitochondrial function is a critical event in triggering apoptosis, as discussed later.
MITOCHONDRIA AS THE
APOPTOTIC TRIGGER
Correlative evidence that altered mitochondrial func tion is an early, potentially causal event in the apoptotic pathway in a variety of cell types is plentiful. These data include measurements of early decreases in tetrazolium bromide reduction (Vukmanovic and Zamoyska, 1991; Deckwerth and Johnson, 1993; Jacobson et aI., 1994; Ankarcrona et aI., 1995) , which may be indicative of decreased mitochondrial respiratory function (Slater et aI., 1963) . Others have measured a decrease in respira tory rates (Krippner et aI., 1996) or the degree to which oxidative phosphorylation (ATP production) is coupled to electron transport (Myers et aI., 1995; Vayssiere et aI., 1994; Cai and Jones, 1998) . In addition, numerous stud ies of diverse cell types responding to widely divergent apoptotic stimuli indicate an early drop in the mitochon drial membrane potential (reviewed by Kroemer et aI., 1997) . As discussed earlier, such a drop might be ex pected in Ca 2 + -mediated forms of apoptosis. However, many of these apoptotic paradigms involved signals de void of a pathologic increase in cytosolic Ca 2 + (Baffy et aI., 1993; Koh et aI., 1995) .
These data are simply correlative. Mitochondrial func tion has been observed to change early in the apoptotic process, well before evidence of nuclear condensation or loss of plasma membrane integrity. The most compelling evidence for a causal role for altered mitochondrial func tion in apoptosis has been provided by cell-free recon stitution assays (Newmeyer et aI., 1994; Liu et aI., 1996; Zamzami et aI., 1996b; Yang et aI., 1997; Kluck et aI., 1997; Ellerby et aI., 1997) . Initially, Newmeyer and co workers (1994) subfractionated egg extracts and found that when cytosol and nuclei were recombined, a dense organelle fraction enriched in mitochondria was required for the induction of nuclear condensation or fragmenta tion. Others have confirmed this result, adding the caveat that the mitochondria capable of inducing nuclear changes must be either damaged or functionally altered (Liu et aI., 1996; Zamzami et aI., 1996) . Liu et aI. (1996) suggest that damaged mitochondria release cytochrome c, which ultimately stimulates the caspase family prote ase CPP-32 (caspase-3) and nuclear condensation when in the presence of cell cytosol and deoxyadenosine tri phosphate (dATP). Cytochrome c is an approximate 13kd electron transport protein normally localized to the mitochondrial intermembrane space, where it electro statically associates with the outer leaflet of the inner mitochondrial membrane (Fig. 4) . Kluck et aI. (1997) and Yang and coworkers (1997) have confirmed this potential activity of cytochrome c by assessing the trans location of this protein into the cytosolic fraction of cells treated with the protein kinase inhibitor staurosporine, etoposide, H 2 0 2 , or ultraviolet radiation. Ellerby et al. (1997) found similar results in a neural cell version of this assay using staurosporine, tamoxifen, mastoparan, or atractyloside as the inducing agents. Microinjection of cytochrome c can induce apoptosis in some cells with the exception of those lacking expression of caspase-3 (Li et aI., 1997a; Zhivotovsky et aI., 1998; Duckett et aI., 1998) . The studies using reconstitution assays also pro vide evidence that the mechanism by which the antiapop totic protein Bcl-2 protects from apoptosis is through inhibition of cytochrome c release from mitochondria (however, see Adachi et aI., 1997) . These studies sug gest, as do others (Newmeyer et aI., 1994; Susin et aI., 1996) , that Bcl-2 must be localized to mitochondria to have a significant antiapoptotic effect. Using a cell-free system in which cell cytosol is not required, associates (1996, 1997) suggest that functionally altered mitochondria release apoptosis inducing factor (AIF), which is a protease (approximately 50 kd) that can stimu late the late stages of apoptosis. Reports also document mitochondrial localization of caspase-3 and caspase-7 (Mancini et aI., 1998; Chandler et aI., 1998) . Therefore, mitochondria can release apoptogenic factors that acti vate the late steps of apoptosis.
How can the data from cell-free systems supporting a role for mitochondria in apoptosis be extrapolated to physiologic systems? To be convincing, cytochrome c activation of these late stages of apoptosis must be spe cific, and translocation to the cytosol must occur in intact cells. Lending an indication of specificity, Yang et aI. (1997) have indicated that apocytochrome c, (which lacks the heme-containing moiety normally inserted by heme lyase in the intermembrane space) cannot activate caspase-3. Ellerby et aI. (1997) found that lysines on the surface of the cytochrome c molecule are critical in the process of caspase-3 activation, since acetylated cyto chrome c was unable to stimulate the activation of caspase-3. Numerous studies have now documented the release of cytochrome c to the cytoplasm in various apoptotic models, including NGF withdrawal-induced neuronal apoptosis (Neame et aI., 1998; Deshmukh and Johnson, 1998) . The latter study supports that cytosolic cytochrome c is not sufficient for execution of the apop to tic scheme in sympathetic neurons. Cytochrome c also redistributes to the cytoplasm following cerebral isch emia in rats (Fujimura et aI., 1998; Perez-Pinzon, 1999) , although it cannot be eliminated that this process occurs as a consequence of osmotic lysis of mitochondria during necrotic cell death. Additional translocation data in intact tissues is warranted, and it should be confirmed that the increase in cytosolic cytochrome c is derived from mi tochondrial release of heme-containing protein, as op posed to an increase in cytosolic apocytochrome c.
The biochemical role that cytochrome c plays in acti vating the late steps of apoptosis is unclear, but details are being revealed. At least three cytosolic proteins (tenned Apaf-l, Apaf-2, and Apaf-3 for apoptotic prote ase activating factors) have been identified by Wang's group to be required for caspase activation in their ap optosis reconstitution assay (Liu et aI., 1996; Zou et aI., 1997) . The group identified Apaf-2 as cytochrome c (Liu et aI., 1996) and found that cytochrome c can bind to Apaf-l (Li et aI., 1997c) , which shares homologic fea tures with the apoptotic death protein in the nematode Caenorhabditis eiegans, termed CED-4 (Zou et aI., 1997) . Evidence has been presented that Apaf-3 is caspase-9, which binds to Apaf-l in the presence of cy tochrome c and dATP, and ultimately activates caspase 3 (Li et aI., 1997c; Zou et aI., 1997) . Redox activity of cytochrome c is not critical to caspase-3 activation (Hampton et aI., 1998) . A link in the pathway beyond cytochrome c activation of caspase-3 to DNA fragmen tation has been provided in a study by Liu et aI. (1997) in which a cytosolic heterodimeric protein, called DNA fragmentation factor, was identified and was found to be cleaved by caspase-3, allowing the DNA fragmentation factor to initiate DNA degradation in intact nuclei.
One of the most intriguing issues to be resolved is the mechanism by which cytochrome c or AIF leaves the intermembrane space. Kroemer et aI. (1997) propose that opening of the PTP is responsible for both the drop in d tIJ measured in many cell types undergoing apoptosis and for the release of apoptogens that stimulate the late steps of apoptosis for which others have provided evidence (Kantrow and Piantadosi, 1997; Scarlett and Murphy, 1997) . Because of a lack of definitive measurement of pore formation in intact cells (a drop in the membrane potential and mitochondria swelling are not exclusively indicative of PTP fonnation), these data are primarily correlative. How does the opening of a pore linking the matrix to the cytoplasmic space control the loss of pro teins from the intermembrane space (Fig. 4) ? The pore, as characterized, is not large enough to allow cytochrome c or AIF to directly traverse .• However, Ca 2 + -or PTP induced mitochondrial swelling could rupture the outer membrane, thereby releasing cytochrome c and other in termembrane space proteins, given the small amount of surface area of the outer versus the inner membrane (Chappel and Crofts, 1965; Pfeiffer et aI., 1995) . Such swelling could be accompanied by a more persistent drop in d tIJ (even if PTP opening is transient), since the loss of cytochrome c from the intermembrane space could be come rate-limiting for respiration (for instance, see Kim et aI. 1997; Cai and Jones, 1998; Krippner et aI., 1996; Adachi et aI., 1997) .
There are two current conflicts associated with the theory that the PTP, or other nonspecific pore formation, is responsible for apoptogen release in all forms of apop totic death. First, mitochondrial swelling should theoret ically accompany nonspecific pore formation. Yet, swelling is not a hallmark morphologic change associ-J Cereb Blood Flow Metab. Vol. 19. No. 3, 1999 ated with apoptotic death. In fact, the lack of organellar swelling is noted as a general characteristic of apoptosis (Kerr et aI., 1972) . Morphologic descriptions of apopto sis may have not have detected mitochondrial swelling because this may be an early, transient event in vivo. Mitochondria have been documented to swell early in the pathway of Fas-mediated apoptosis (Krippner et aI., 1996; Vander Heiden et aI., 1997) . Others have found mitochondrial swelling in HIV-induced apoptosis (Car bonari et aI., 1997) . The possibility also exists that swell ing of only a small fraction of the mitochondrial popu lation may be required to release sufficient apoptogen, although this seems to be a risky strategy for survival in an evolutionary sense. It may be relevant that conditions have been described for the release of matrix compo nents from isolated mitochondria in the absence of de tectable large-amplitude swelling, yet electron micro graphs indicate that a fraction of the mitochondria under these conditions are slightly swollen (Reed and Savage, 1995) . So, it is possible that mitochondrial swelling does take place in apoptosis but largely goes undetected.
The second problem with nonspecific pore formation as the sole mechanism for apoptogen release is that sev eral researchers have presented data arguing that there is no measureable drop in d tIJ before cytochrome c release (Yang et aI., 1997; Kluck et aI., 1997; Kim et aI. 1997; Vander Heiden et aI., 1997; Richards et aI., 1997; Bossy Wetzel et aI., 1998; Cai and Jones, 1998) . These studies raise several issues, both technical and theoretical. Re gardless of the caveats that follow, these studies present the possibility that the specific apoptotic stimulus may determine whether there is a measureable loss in d tIJ before cytochrome c translocation. It may be reasonably theorized that stimuli that involve significant mitochon drial Ca 2 + loading or prooxidant stress induce the release of cytochrome c through PTP stimulation. Alternatively, the signaling process to mitochondria from stimuli such as staurosporine or trophic factor withdrawal is less clear and could involve novel pathways impinging on mito chondrial function and cytochrome c release. Techni cally, several issues that should be considered when evaluating these data. For measurement of mitochondrial membrane potential to be informative, mitochondria must be provided with a respiratory substrate and with a dye that is membrane potential-sensitive without second ary effects on the sulfhydryl redox status of the mito chondria. Otherwise, the data are uninterpretable. The methods also should be quantitative and sensitive at lev els of high membrane potential, since it is possible that a drop in d tIJ resulting from a permeability transition may only have to occur in a fraction of the mitochondrial population to propagate the apoptotic signal. This is complicated by the fact that as a subpopulation of mito chondria depolarize, others with nonnal d tIJ may accu mulate the excess cationic dye, ultimately resulting in little or no detectable change in fluorescence. Evaluation of the behavior of the fluorescent dye over a range of uncoupler concentrations is important to understanding the effect of dye quenching on the fluorescent signal as mitochondria depolarize. That is, the fluorescence of rhodamine 123 can increase as mitochondria depolarize from dequenching of the dye (Emaus et aI., 1986) . This behavior of the dyes makes increases in fluorescence difficult to interpret with respect to changes in /llj!.
As reports now indicate that cytochrome c can be re leased in the absence of the permeability transition as conventionally defined (Andreyev et aI., 1998) , identifi cation of the mechanism responsible for such release is imperative. In this circumstance, either swelling takes place that does not compromise /llj!, or a specific mecha nism for translocation of apoptogens across the outer membrane must exist. With regard to swelling, mecha nisms of the control of mitochondrial volume have been described, and resistance of isolated mitochondria to hy potonic stress is known to involve activity of the K+/H+ antiporter that is driven by /lpH (Brierley et aI., 1994; Halestrap, 1989) . If an apoptotic signal involves a swell ing stress to mitochondria, then observations of hyper polarization before apoptogen release may be real. That is, providing that the total proton motive force remains constant, /lpH could collapse in an attempt at volume regulation, whereas /llj! would commensurately increase. In considering some type of specific channel, the largest known channel in the outer membrane is formed by mi tochondrial porin, also known as the voltage-dependent anion channel, which may accommodate molecules as large as 8 kd under certain conditions (De Pinto and Palmieri, 1992) . This may not be large enough to trans locate the approximately 15-kd cytochrome c and is not large enough for the approximately 50-kd AIF. Other theoretical possibilities include reversal of the protein import process (Mayer et al. 1995) or specific facilitation by membrane components. It also has been proposed that the mitochondrial outer membrane is a target for specific proteolysis early in Fas-induced apoptosis (Susin et aI., 1997; Krippner et aI., 1996) .
Development of a theoretical mechanism for apopto gen release also must consider current x-ray and NMR data suggesting that Bcl-xL shares some structural ho mologic features to the domains of bacterial toxins that form pores in membranes (Muchmore et aI., 1996) . This predicted function has been confirmed in electrophysi ologic studies demonstrating ion conductance (most pre dominant at acidic pH) by recombinant Bcl-xL and Bcl-2 in phospholipid bilayers (Minn et aI., 1997; Schendel et aI., 1997; Schlesinger et aI., 1997) . Antonsson and others (1997) have shown that recombinant Bax forms channels in liposomes, allowing pre loaded carboxyfluorescein (molecular weight -376d) to be released at physiologic pH, although acidic pH significantly enhanced the rate and extent of release. This Bax-induced release of fluo rescent dye was inhibitable by recombinant Bcl-2. Re cent evidence suggests that Bax may induce cytochrome c release and caspase activation in a CsA-sensitive man ner, suggestive of induction of the PTP (Pastorino et aI., 1998; Jiirgensmeier et aI., 1998; Narita et aI., 1998) . In contrast, Eskes et al. (1998) have suggested that the ef fects of Bax are not mediated by the PTP as convention ally defined. Since Bax may play an important role in trophic factor withdrawal-induced apoptosis in neurons (White et aI., 1998) , a clearer understanding of the mechanism of action of Bax is warranted.
How could channel formation in mitochondria be in corporated into a hypothesis for regulated control over apoptosis? It is difficult to devise a theoretical scenario in which an antiapoptotic protein would form a K+ or Cl channel that could operate to the advantage of the mito chondria, given that the ultimate function of these organ elles is highly dependent on the impermeability of the inner mitochondrial membrane to such ions. For in stance, a K+ -specific channel would allow this ion to move down the electrical gradient, dissipating /llj! and potentially inducing mitochondrial swelling, which might be more appropriate as a theoretical mechanism for a proapoptotic factor such as Bax. Theoretically, it is possible to ascribe K+ or Cl-channel function to anti apoptotic proteins if they are linked to energy-dependent translocation of osmotically active ions out of the matrix (possibly to enhance mitochondrial volume homeosta sis). It is known that the mitochondria of control and bcl-2-overexpressing cells have virtually identical respi ratory properties under control conditions (Myers et aI., 1995; Murphy et aI., 1996; Murphy and Fiskum, 1996) ; therefore, there is no current evidence that antiapoptotic proteins such as Bcl-2 act to enhance respiration or de crease the level of uncoupling under control conditions. However, it is clear that Bcl-2 preserves electron trans port function in response to stress (Murphy et aI., 1996a,b; Myers et aI., 1995; Shimizu et aI., 1998) . Whether this ability to maintain electron transport in re sponse to prooxidant or Ca 2 + -induced stress is solely the result of the ability of BcI-2 to block cytochrome c re lease requires further investigation.
There also is current evidence that kinase-mediated signal transduction cascades regulate the function of BcI-2 and its proapoptotic homologue, Bad, at the mito chondria (Gajewski and Thompson, 1996) . Survival fac tor signaling through the interleukin-3 receptor on hema topoietic cells results in the phosphorylation of Bad, pre venting apoptosis potentially by inhibiting Bad's sequestration of Bcl-2 or BcI-xL through heterodimeriza tion (Zha et aI., 1996) . Wang and others (1996) have provided evidence that Bc1-2 is involved in targeting Raf-l (a kinase known to be involved in ras-mediated growth factor signaling) to mitochondria, which may ul-timately result in phosphorylation and inhibition of Bad. Furthermore, serine phosphorylation of Bel-2 has been reported to alter its antiapoptotic activity (Haldar et ai., 1997) , and deletion of a regulatory region of Bel-2, which contains multiple serine/threonine phosphoryla tion sites, extends the ability of Bel-2 to prevent apop tosis (Chang et ai., 1997) .
Translocation of regulatory molecules to allow for specific protein-protein interactions at the mitochondrial membrane may be important in apoptogen release. Spe cifically, Bax and Bel-XL shift from cytosolic-to mem brane-bound forms during thymocyte apoptosis, whereas Bel-2 is found consistently to be membrane bound (Hsu et ai., 1997) .
Unanswered questions
Critical issues with regard to the mechanism of mito chondrial apoptogen release remain to be resolved. If there are exceptions to permeability transition-mediated apoptogen release, are the exceptions relevant patho physiologic conditions? That is, does staurosporine induced apoptosis mimic a disease process that makes this alternative mechanism a target for therapeutics? Is this alternative mechanism mediated by mitochondrial swelling or by some more specific event allowing for apoptogen release? Alternatively, is the permeability transition mediating all forms of apoptogen release, and in a subset of apoptosis paradigms this occurs to an un detectable portion of the total mitochondrial population? On a more basic level, we need to understand the degree to which the apoptotic pathway contributes to neuronal dysfunction in neurodegenerative diseases. Is early de mentia in Alzheimer's disease caused by an abortive apoptotic pathway that creates chronic cell dysfunction? These are only a few of the critical questions for under standing the role that mitochondria play in neurodegen eration, and the answers will facilitate rationale thera peutic design.
